Zhigang Zhang, PhD

Associate Attending Biostatistician
Epidemiology & Biostatistics
Directory
Epidemiology
Biostatistics
Health Outcomes
Computational Oncology
Administrative Resources
Career Opportunities
Educational Opportunities
Departmental Newsletter

Zhigang Zhang, PhD

Associate Attending Biostatistician
Share
Share
Zhigang Zhang, PhD

Email

zhangz@mskcc.org

Education

University of Missouri-Columbia

Current Research Interests

Dr. Zhang’s current research interests are in survival analysis, longitudinal data analysis and semiparametric inferences. In particular, he is interested in developing methodology for data subject to complicated censorship and/or truncation, which frequently arise in clinical trials and medical studies. He is also interested in statistical research aimed at clinical trials. Dr. Zhang collaborates with colleagues in the Department of Radiation Oncology, the Department of Medical Physics and the Neuroradiology Service.

Publications

Selected peer-reviewed publications:

  1. S. Liuquan and Z. Zhang (2009). A class of transformed mean residual life models with censored survival data. Journal of the American Statistical Association 104, 803-815.
  2. Z. Zhang (2009). Linear transformation models for interval-censored data: Prediction of survival probability and model checking. Statistical Modeling 9, 321-343.
  3. Z. Zhang, X. Zhao and L. Sun (2010). Goodness-of-fit tests for additive mean residual life model under right censoring. Lifetime Data Analysis 16, 385-408.
  4. L. Sun, X. Song and Z. Zhang (2012). Mean residual life models with time-dependent coefficients under right censoring. Biometrika 99, 185-197.
  5. Z. Zhang and Y. Zhao (2013). Empirical likelihood for linear transformation models with interval-censored failure time data. Journal of Multivariate Analysis 116, 398-409

Visit PubMed for a full listing of Zhigang Zhang’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Zhigang Zhang discloses the following relationships and financial interests:

No disclosures meeting criteria for time period


The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.


View all disclosures